Results 41 to 50 of about 301,780 (222)
Background/Aims: The increase in the survival rate of patients with chronic renal failure due to substitution treatment prompts an investigation of their quality of life (QoL), a key measure to evaluate the outcomes of chronic disease treatment.
L. Zazzeroni+4 more
semanticscholar +1 more source
Computational analysis for competition flows in arteriovenous fistulas based on non-contrast magnetic resonance imaging [PDF]
Introduction: Characteristics of hemodynamics strongly affect the patency of arteriovenous fistula (AVF) in hemodialysis patients. Because of pressure balance changes among arteries after AVF construction, regurgitating flow occurs in some patients.
arxiv
Hemodialysis‐induced cardiovascular disease
More than half of all deaths among end stage renal disease (ESRD) patients are due to cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction, including fluid overload, uremic cardiomyopathy, secondary hyperparathyroidism ...
S. Ahmadmehrabi, W. Tang
semanticscholar +1 more source
Date-Driven Approach for Identifying State of Hemodialysis Fistulas: Entropy-Complexity and Formal Concept Analysis [PDF]
The paper explores mathematical methods that differentiate regular and chaotic time series, specifically for identifying pathological fistulas. It proposes a noise-resistant method for classifying responding rows of normally and pathologically functioning fistulas.
arxiv
BACKGROUND Arteriovenous fistulas (AVFs) are the preferred form of hemodialysis vascular access, but maturation failures occur frequently, often resulting in prolonged catheter use.
K. Woodside+11 more
semanticscholar +1 more source
Summary o 1. The clinical observation of acute schizophrenic patients, particularly of cases of catatonia, leads to the assumption of a toxin as a concomitant cause (“Mitursache”) in this psychosis. On the basis of this assumption hemodialysis was performed to eliminate from the blood a (hypothetical) toxin. 2.
Massini Ma, Staub H, H. Feer, Thoelen H
openaire +3 more sources
An open‐label, parallel‐group, single‐dose study was conducted to assess the pharmacokinetics, pharmacodynamics, and safety of apixaban in 8 subjects with end‐stage renal disease (ESRD) on hemodialysis compared with 8 subjects with normal renal function.
Xiaoli Wang+9 more
semanticscholar +1 more source
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
BACKGROUND Atherosclerosis, a major problem in patients on chronic hemodialysis, has been characterized as an inflammatory disease. C-reactive protein (CRP), the prototypical acute phase protein in humans, is a predictor of cardiovascular mortality in ...
J. Zimmermann+4 more
semanticscholar +1 more source
<b><i>Background:</i></b> Asia is the largest, most populous and most heterogeneous continent in the world. The number of patients with end-stage renal disease is growing rapidly in Asia. <b><i>Summary:</i></b> A fully informed report on the status of dialysis therapies including hemodialysis (HD) is ...
Narayan Prasad, Vivekanand Jha
openaire +3 more sources
Vascular access for hemodialysis: A perpetual challenge
Vascular access for hemodialysis has a long and rich history. This article highlights major innovations and milestones in the history of angioaccess for hemodialysis.
M. Murea+3 more
semanticscholar +1 more source